11 Nov Corporate funding and potential conflict of interest in public health скачать в хорошем качестве

11 Nov Corporate funding and potential conflict of interest in public health

HSR 2020 Organized session: Corporate funding and potential conflict of interest in public health: An interactive audience and panel discussion Evidence highlights a range of ways in which conflicts of interests that originate from the corporate funding of research and practice can bias research findings and public health practice. The risks attendant on receiving funding for public health from tobacco, alcohol, pharmaceuticals, and gambling industries are well documented in the academic literature. University researchers, for example, caution against accepting such funds because of the interference of industries in the research process, especially in data management and analysis, in the interpretation of results, and limiting researchers’ autonomy in publishing findings. Corporate funding can also shape research agendas in ways that work against public health. There is a paucity of guidelines aimed at managing whether, how and under what conditions academic and public health institutions receive funds from for-profit corporations. Consequently, corporate funding of academic research and public health practice varies across organizations, and in many instances, the decision to accept corporate funding is left to the discretion of individual researchers or the institution. The session will discuss scenarios originally developed for an online survey designed to assess attitudes and practices of public health academics and practitioners about accepting funds from a variety of for-profit corporations, conducted as part of a larger IDRC funded study. The scenarios are based on models of funding partnerships between academic institutions and corporations, and vary by grant size (in USD), grant type, corporation type, target population, and type of research.